Lens subluxation is more efficiently managed by phacoemulsification

Article

Lens subluxation and lens coloboma are better managed by phacoemulsification rather than manual small incision cataract surgery (MSICS).

Lens subluxation and lens coloboma are better managed by phacoemulsification rather than manual small incision cataract surgery (MSICS), reveals a study in The Journal of the British Contact Lens Association.

The investigation, led by Dr Saurabh Kamal, Guru Nanak Eye Centre, New Delhi, India, included a patient with bilateral isolated lens coloboma. In the left eye MSICS was performed and in the right eye phacoemulsification was conducted.

Lens extraction was indicated for cataract or subluxation by determining if visual function was adequately compromised.

The results revealed that nuclear rotation was disturbed due to a lack of zonules and lens coloboma presence. In the right eye the nucleus was broken during phacoemulsification. This allowed the successful implantation of a modified capsule tension ring.

In conclusion, eyes with lens coloboma are more at risk of complications during cataract surgery, so phacoemulsification is the safest and most successful treatment option.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.